Hematologic Tests: Clinical Trials

17 trials of Hematologic Tests, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed, 3 unknown, 2 terminated, 1 active not recruiting. 17 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 217Completed 8, Unknown 3, Terminated 2, Active not recruiting 1, Enrolling by invitation 1, Recruiting 1, Withdrawn 1
Phase 31Completed 1

Follow Hematologic Tests: new trials by email Literature Review of Hematologic Tests trials Research Report on Hematologic Tests

Trials (filtered) newest first · largest first

All 17 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Trial for Local Ablative Treatment (LAT) Optimization in Patients With Advanced Non-Small Cells Lung Cancer (NSCLC) Presenting an Anaplastic Lymphoma Kinase (ALK) Rearrangement Treated by Brigatinib
Blood samples for Hematology, Blood samples for Chemistry, Blood sample for liver function tests - NSCLC
Phase 2RecruitingGroupe Francais De Pneumo-Cancerologie452025-06-192026-04-29
Study of Safety and Efficacy of MGCND00EP1 as an Add on Treatment in Children and Adolescents With Resistant Epilepsies
MGCND00EP1, Placebo, ECG - Resistant Epilepsy, Drug, Adolescent Epilepsy
Phase 2WithdrawnMGC Pharmaceuticals d.o.o2024-05-302024-06-03
A Randomised, Controlled Trial of a Low-energy Diet for Improving Functional Status in Heart Failure With PRESERVED Ejection Fraction Preserved Ejection Fraction
Low calorie meal replacement plan, Cardiovascular magnetic resonance (CMR) imaging and magnetic resonance spectroscopy, Transthoracic echocardiography - Heart Failure With Preserved Ejection Fraction, Heart Failure, Diastolic
Phase 2 / Phase 3CompletedUniversity of Leicester662023-12-052026-07-22
Immunologic Changes and Recovery-related Factors in Elderly Colon Cancer Patients
Blood test - Cancer of Colon, Interleukins
Phase 2CompletedSoonchunhyang University Hospital752023-09-042024-06-12
Targeting Neuroinflammation as a Contributing Pathology in Alzheimer's Disease Dementia and Related Dementias
C-11 ER-176, Blood Test - Lewy Body Dementia (LBD), Alzheimer Dementia (AD)
Phase 2Enrolling by invitationVal Lowe1252021-03-302026-05-22
Randomized Placebo Controlled Trial Evaluating the Efficacy of Pimavanserin, a Selective Serotonin 5-HydroxyTryptamine-2A (5HT2A) Inverse Agonist, to Treat Impulse Control Disorders in Parkinson's Disease.
Active drug: pimavanserin 17mg (2 strength tablets), Placebo: 2 tablets containing same excipients except active compound, Assessment of severity of ICD (impulse control disorders) - Parkinson Disease
Phase 2CompletedUniversity Hospital, Strasbourg, France1172020-10-232026-03-16
Screening and Multiple Intervention on Lung Epidemics
Cytisine, Acetylsalicylic acid, Diet Modification and Physical Activity Increase - Inflammation, Smoking Cessation
Phase 2Active not recruitingFondazione IRCCS Istituto Nazionale dei Tumori, Milano20002019-07-232026-03-27
Efficacy Evaluation of Focused HIFU (High Intensity Focused Ultrasound) Therapy in Patients With Localized Intermediate Risk Prostate Cancer
treatment with focal HIFU, PSA dosage, MRI - Prostate Cancer
Phase 2CompletedHospices Civils de Lyon1742018-09-282026-02-24
Anti-Mesothelin Antibody Drug Conjugate Anetumab Ravtansine for Mesothelin Expressing Lung Adenocarcinoma
Anetumab Ravtansine, Blood test - Lung Neoplasms
Phase 2TerminatedNational Cancer Institute (NCI)22016-07-192019-05-21
Chemical Renal Ethanol Sympatholysis Under CT Guidance Use for the Control of Therapy-Resistant Hypertension
Renal sympathicolysis, Ambulatory Blood Pressure Monitoring, Magnetic Resonance Angiography - Hypertension Resistant to Conventional Therapy, Kidney Failure, Chronic
Phase 2TerminatedUniversity Hospital, Grenoble22016-02-012018-05-09
Pre-operative Studies for Prediction of Lymph Nodes Involvement in Endometrial Cancer Patients
ultrasound, blood test - Endometrial Cancer
Phase 2UnknownMeir Medical Center2002015-10-012016-09-20
A Biomarker Study of Standard-of-care Radium-223 Chloride for Metastatic Castration-resistant Prostate Cancer
Blood Tests, CT scan, FACBC PET/MRI in a subset of participants - Prostate Cancer, Castration-resistant Prostate Cancer
Phase 2CompletedMassachusetts General Hospital222015-04-012022-09-29
Oral Steroids for Regorafenib-induced Fatigue/Malaise in Unresectable mCRC (KSCC1402/HGCSG1402)
General condition, Blood pressure, Patient Reported Outcome - Rectal Cancer
Phase 2UnknownClinical Research Support Center Kyush742014-10-012014-11-13
RP II Study of SOX vs mFOLFOX6 in Patients With Resectable Rectal Cancer (KSCC1301).
Laboratory test, Medical history and physical examination, BW and height - Rectal Cancer
Phase 2UnknownClinical Research Support Center Kyush1102013-09-012014-10-31
Evaluation of Meningococcal ACWY Immune Response in Children Aged 40 and 60 Months
MenACWY-CRM197, Blood test - Meningococcal Disease
Phase 2CompletedNovartis Vaccines3822008-02-012014-10-24
A Study To Measure The Level Of Drug In Nasal Tissue And Blood After Taking A Single 2g Dose Or 500mg Tablets For Up To
Zithromax™ (azithromycin) 500mg tablets, Endoscopic Sinus Surgery, Blood sampling for hematology - Sinusitis
Phase 2CompletedPfizer722005-11-012011-04-21
Interstitial Cystitis
H&P; ECG; Blood tests; voiding diary; Cystoscopy - Interstitial Cystitis
Phase 2CompletedICOS Corporation1502003-01-012005-06-24

Conditions studied

Lung Neoplasms (3)  ·  Prostatic Neoplasms (2)  ·  Rectal Neoplasms (2)  ·  Adenocarcinoma of Lung (1)  ·  Alzheimer Disease (1)  ·  Behavior (1)  ·  Colonic Neoplasms (1)  ·  Cystitis, Interstitial (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Disruptive, Impulse Control, and Conduct Disorders (1)  ·  Drug Resistant Epilepsy (1)  ·  Endometrial Neoplasms (1)  ·  Epilepsy (1)  ·  Fatigue (1)  ·  Heart Failure, Diastolic (1)

Sponsors

Clinical Research Support Center Kyush (2)  ·  Fondazione IRCCS Istituto Nazionale dei Tumori, Milano (1)  ·  Groupe Francais De Pneumo-Cancerologie (1)  ·  Hospices Civils de Lyon (1)  ·  ICOS Corporation (1)  ·  MGC Pharmaceuticals d.o.o (1)  ·  Massachusetts General Hospital (1)  ·  Meir Medical Center (1)  ·  National Cancer Institute (NCI) (1)  ·  Novartis Vaccines (1)  ·  Pfizer (1)  ·  Soonchunhyang University Hospital (1)  ·  University Hospital, Grenoble (1)  ·  University Hospital, Strasbourg, France (1)  ·  University of Leicester (1)

Countries

United States (5)  ·  France (4)  ·  Israel (2)  ·  Japan (2)  ·  United Kingdom (2)  ·  Canada (1)  ·  Italy (1)  ·  Slovenia (1)  ·  South Korea (1)

Top investigators

Yasunori Emi, MD, PhD (2)  ·  Byeo Lee Lim, Dr (1)  ·  Gerry P McCann, MD (1)  ·  Julien Ghelfi, Md (1)  ·  Lyn Frumkin, M.D., Ph.D. (1)  ·  Philip J Saylor, MD (1)  ·  Raffit Hassan, M.D. (1)  ·  Rubi Zomer (1)  ·  Ugo Pastorino, MD (1)  ·  Val Lowe, MD (1)

Results publications

PMID 22394992, PMID 39880434

NIH funding

2016 (2), 2015 (1)